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Abstract 14-3-3 proteins play a role in many cellular functions: 
they bind to and regulate several proteins which are critical for 
cell proliferation and differentiation. 14-3-3 proteins exist as 
dimers, and in this study we have shown that diverse 14-3-3 
proteins can form both homo- and heterodimers in vitro (by cross- 
linking studies) and in vivo (by coimmunoprecipitation a d West- 
ern blot analysis); this interaction is mediated solely through the 
N-terminal domain of the proteins. The composition of 14-3-3 
dimers within a cell may play a key part in the role of this family 
of proteins as modulators or adapters which facilitate the interac- 
tion of distinct components of signalling pathways. 
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1. Introduction 
The 14-3-3 protein family was so named due to its migration 
position on two-dimensional DEAE chromatography and 
starch gel electrophoresis [1]. 14-3-3 proteins have a molecular 
mass of  around 30 kDa and are highly conserved in evolution. 
They have been found in mammals, insects, plants, yeast, am- 
phibians, fish and Caenorhabditis elegans, and have been as- 
signed a wide variety of functions (reviewed in [2] and [3]). To 
date, seven mammalian brain isoforms of 14-3-3 have been 
described, named a-r/after their respective lution positions on 
HPLC [4]. Five of these have been sequenced (reviewed in [5]), 
and the ~ and ~ isoforms are phosphorylated forms of the fl and 
isoforms respectively [6]. This phosphorylation is at a consen- 
sus motif  for proline directed (cyclin-dependent) kinases. Addi- 
tional isoforms which are absent or present at low levels in 
brain have been described from other mammalian tissues; these 
include an isoform found in T-cells [7] and one in epithelial cells 
[8,9]. These have been named r and 0 respectively [10]. 
14-3-3 proteins have been ascribed a diverse range of activi- 
ties including regulation of protein kinase C activity, involve- 
ment in exocytosis from adrenal chromaffin cells, transcrip- 
tional regulation in plants and regulation of the cell cycle in 
fission yeast (reviewed in [2] and [3]). Recently the fl and ~" 
isoforms (which are phosphorylated in vivo at a high stoichiom- 
etry in brain [6]) have been shown to associate with (and possi- 
bily activate) Raf-1 kinase in the cytosol and at the membrane 
of mammalian cells and in yeast [11-15]. The r isoform has been 
shown to bind, and be phosphorylated by, c-Bcr and Bcr-Abl 
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kinases, and may also regulate these proteins [16]. 14-3-3 
isoforms have also been shown to bind polyoma virus middle 
tumour antigen, a protein which associates with other cellular 
proteins involved in the regulation of cell proliferation [17]. 
In this study we have shown that several specimen isoforms 
can form homo- and heterodimers both in vivo and in vitro. 
This finding is of importance in the elucidation of the physio- 
logical role of this family of proteins. 
2. Materials and methods 
2.1. DNA manipulations and protein purification 
DNA manipulations were performed in Escherichia coli TBI (New 
England Biolabs). Plasmids pMALc2 (which produces amaltose-bind- 
ing protein fusion; New England Biolabs) and pKK233-2 (which pro- 
duces a native protein; Pharmacia) were used as expression vectors. The 
~" isoform was cloned from a human T-cell cDNA library constructed 
in the vector lambda ZAPII (Stratagene, catalogue number 936204). 
The fragment of DNA containing the open reading frame only, was 
isolated irectly from the library by means of the PCR and ligated into 
expression vector pKK233-3. Oligonucleotides GGAATTCCATGG- 
ATAAAAATGAGCTGGTTCAG (which incorporates a Ncol site im- 
mediately prior to the start codon) and ACGCAAGCTTAATTTTC- 
CCCTCCTTCTCCTGC (which incorporates a HindllI site after the 
stop codon) were used for this purpose. Optimum recovery of the ~" 
cDNA was achieved with 1/A of library (as supplied) in a 50 ~1 reaction 
volume. Prior to the addition of buffer, primers and enzyme, the library 
aliquot was disrupted by incubation at 70°C for 5 minutes, and was 
then cooled on ice. Taq polymerase was added when the reaction mix 
was at 94°C, and this was subjected to 30 cycles of the PCR of 1 minute 
at 94°C, 2 minutes at 54°C and 1 minute 45 seconds at 72°C. This was 
sequenced by the dideoxy chain termination method using the Se- 
quenase kit supplied by USB. Protein purification (both of the fusion 
proteins, and those expressed as native 14-3-3 proteins) was performed 
as described in [19]. To generate vectors for expression in eukaryotic 
cell culture, 14-3-3 isoforms were manipulated into the expression vec- 
tor pcDNA3 (Invitrogen) using the PCR and suitable oligonucleotides. 
For expression of isoforms with a C-terminal myc-tag (MEQKLISEE- 
DLN), the coding DNA was first ligated into a Bluescript vector which 
already contained the coding sequence for the myc-tag inserted between 
the BamHI and XbaI restriction sites. The 14-3-3 cDNA and tag DNA 
were then excised together and inserted into pcDNA3. 
The N-terminal 17 kDa portion of 14-3-3 proteins forms a domain 
which is stable and soluble when expressed in E. coli [19]. This domain 
of e 14-3-3 was also inserted into pcDNA3 as a myc-tag, and expressed 
well. N-terminally deleted e(which can be expressed in E. coli [19]) did 
not produce any detectable protein expession however. Full details of 
plasmids generated can be obtained from the authors. 
2.2. Protein cross-linking 
20/zg of e or r maltose-binding protein fusions or MBP alone, and 
10/zg of non-fusion ~" or r protein were mixed as required (this gives 
near equal molar ratios of the proteins) and made up to 100/zl in 20 
mM Tris pH 7.5 + 1 mM DTT. A solution of 8M guanidine HC1 was 
then added to each tube to a final concentration f6 M and these were 
incubated at room temperature for 2 hours. Samples were then dialysed 
against several changes of PBS + 1 mM DTT. Titration of BS 3 
(bis[sulphosuccinimidyl] suberate) cross-linking reagent (Pierce) 
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against ( isoform indicated that a molar ratio of 140:1 BS3: ( gave 
approximately 50% cross-linking after one hour at room temperature, 
which gave sharp protein bands on SDS-PAGE (data not shown). 
Excess cross-linker resulted in blurred cross-linked protein bands. 
Freshly prepared BS 3 was therefore added to the reaction tubes to the 
required concentration, and incubated at room temperature for 1 hour. 
The reaction was stopped by the addition of Tris pH 7.5 to 100 mM. 
The sample volume was reduced by freeze-drying and the mixes were 
then analysed by 8% SDS-PAGE. One gel was stained with Coomassie 
blue and one gel was analysed by Western blotting. 
2.3. Electroporation of COS cells and immonoprecipitation 
Rapidly growing cells were harvested and 2 × 106 cells were electro- 
porated (using a Bio-Rad Gene Pulser at 0.27 V, 125 gFd) with 3/./g 
plasmid DNA + 20 gg sonicated herring sperm carrier DNA. Cells 
were grown for a further 48-60 hours, with one change of medium. Cell 
monolayers were harvested by scraping cells from the bottom of the 
dish in the presence of ice-cold detergent lysis buffer (20 mM Tris 
pH7.5, 150 mM NaC1, 1% NP40, 5 mM iodoacetamide, 5 mg/ml each 
aprotinin and leupeptin, 0.1 mM vanadate). This was rotated at 4°C 
for 1 hour, then debris was removed from the supernatant bymicrocen- 
trifugation at 4°C for 15 minutes. 
Monoclonal antibody 9El0 was bound to protein A Sepharose beads 
(Pharmacia) by the high salt method [20]. Beads were mixed with the 
cell lysate for 2 hours at 4°C, then washed with lysis buffer. Samples 
were analysed by SDS-PAGE analysis [21]. 
2.4. Western blot analysis 
This is described in [10]. Antibodies pecific to each 14-3-3 isoform 
are described in [10], and antibody specific to the C-terminus of e is 
described in [19]. 
3. Results and discussion 
Mammalian 14-3-3 proteins have a molecular weight of circa 
30 kDa (with the exception of s which has an apparent Mr of 
33 kDa) and isoelectric points of circa 4.6. As a result most 
cannot be separated clearly on SDS-PAGE. Cross-linking of 
individual isoforms gives no useful data as all 60 kDa cross- 
linked species have a virtually identical mobility. By crosslink- 
ing a 14-3-3 fusion protein with a native protein this problem 
is overcome. It is important to note that the fusion used in this 
work is the monomeric maltose binding protein (MBP). In 
contrast, glutathione S-transferase is dimeric in its native state. 
Fig. 1 shows the Western blot of r and ( non-fusion proteins 
and r-MBP in all combinations, with or without cross-linker. 
r and ( native proteins cross-link efficiently to give a 60 kDa 
product, v-MBP, which has a monomeric molecular mass of 72 
kDa, cross-links less efficiently to give a product of approxi- 
mately 200 kDa; while this appears high, it should be remem- 
bered that the protein now has some covalent structure and is 
not a totally denatured linear polypeptide. The N-terminal 
amino acids of 14-3-3 are important for dimer formation [19], 
and as the MBP is attached to the N-terminus, the less efficient 
cross-linking may be due to steric effects. 
When r-MBP is cross-linked to ( or r 14-3-3, the 60 kDa and 
200 kDa protein species are again evident. In addition, and with 
equal intensity for both isoforms, a doublet protein species of 
intermediate size (approximately 140 kDa) is present; this is 
r-MPB cross-linked to v and (. Why this should be a doublet 
is unclear, though it could be an artefact depending on where 
the cross-linker binds in the protein sequence. 
To determine whether 14-3-3 proteins can form homo- and 
heterodimers in vivo, epitope tagged s 14-3-3 was transfected 
into COS cells and subsequently immunoprecipitated by means 
of the myc-tag. Any non-tagged 14-3-3 precipitated must be 
dimerised or complexed with the myc-tagged form. Tagged 
14-3-3 proteins have an apparent molecular weight approxi- 
mately 3 kDa higher than untagged proteins, thus any 14-3-3 
protein bound to the tagged isoform will be clearly visible on 
SDS-PAGE. However, transfection with tagged 14-3-3 alone 
resulted in very little co-immunoprecipitation of other 14-3-3 
proteins (data not shown). It has been observed previously 
(from in vivo phosphorylation studies) that 14-3-3 proteins 
have a relatively long half-life (Aitken and Hernandez, pers. 
obs.). Thus the transfected, tagged 14-3-3 proteins, which 
should be translated at a high rate, may associate predomi- 
nantly with themselves, and not with endogeneous proteins 
which are being produced at a much slower rate. To overcome 
this, double transfections of both tagged and non-tagged 
isoforms were performed. Upon immunoprecipitation it was 
clear that non-tagged proteins were dimerising efficiently with 
the myc-tagged versions. Fig. 2 shows that when cells are trans- 
fected with s-myc and either native s or ( 14-3-3, the non- 
tagged proteins are precipitated with s-myc (lanes 5 and 9). In 
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Fig. 1. Western blot of 14-3-3 proteins in the presence (+) or absence (-) of cross-linking reagent. The blot was probed with antibodies specific for 
the N-terminal regions of r and ( 14-3-3 isoforms [10]. Lane 1 shows the presence of the 200 kDa cross-linked r-MBP fusion protein (labelled r fusion), 
and lanes 7 and 9 show the 60 kDa cross-linked product of native ( and r respectively. There is no effect on this cross-linking when MBP alone is 
present (lanes 11 and 13). When z-MBP fusion protein (labelled rf) is cross-linked with either or (however (lanes 3 and 5), an additional band 
of intermediate size is apparent; he dimer of r-MBP/r (lane 3) and r-MBP/( (lane 5). 
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Fig. 2. Western blot (probed with antibodies specific for the N-terminal regions of e and ~" 14-3-3 isoforms) of total soluble cell extract (T) and protein 
immunoprecipitated with anti-myc 9El0 monoclonal ntibody (B). Cells were transfected with vector alone (pcDNA3, lanes 2 and 3) or with vectors 
expressing e-myc, 1/2e-myc (a fusion with the N-terminal domain of e only), e or ~" (lanes 4 through 11) as shown. Lanes 1 and 12 are brain-purified 
14-3-3 protein as a marker: e is the upper band (33 kDa) and ~" is the lower band (30 kDa). The antibody against ~" shows less avidity than the 
antibody. In all 'total' (T) lanes, background e and ~" 14-3-3 (at 33 kDa and 30 kDa) are apparent. Lane 4 shows an additional higher molecular 
weight band at approx. 36 kDa (e-myc), which when immunoprecipitated (lane 5) also brings down ~" 14-3-3 (and a small amount of background 
6). An equivalent pattern is seen with half-length e-myc fusion (with an Mr of 17 kDa, 1/2e-myc, lane 7). The immunoprecipitate of cells transfected 
with e-myc and E shows that e is precipitated with the tagged form, and again some background ~" is precipitated (lane 9). This is also seen in cells 
transfected with half-length E-myc fusion and e (lane 11). 
each case endogenous e or ff are also visible albeit as much 
fainter bands (for reasons described above). The tagged 17 kDa 
N-terminal domain of e 14-3-3 also precipitated intact 14-3-3 
and ~" efficiently (lanes 7 and 11). This is predicted from the 
crystal structure of 14-3-3, which verifies that the N-terminal 
region of 14-3-3 mediates the dimerisation [22]. 
The observation that several specimen isoforms of 14-3-3 can 
form homo- and heterodimers has important ramifications. 
~" has been shown to bind to and activate c-Raf kinase and r 
binds to and is phosphorylated by Bcr and Bcr-Abl kinases. 
Whether each 14-3-3 isoform has a specificity for a single cellu- 
lar protein, is as yet unclear. However it has been shown that 









Fig. 3. Putative function of 14-3-3 heterodimers (labelled 14-3-3 X and Y), as adaptors to bring together distinct regulatory proteins (labelled A and 
B) of signalling pathways. The interaction between A and B may be directed to a membrane, cytoskeletal or organellar location as depicted, if 14-3-3 
interacts through its conserved, negatively charged pocket with a positively-charged protein. The shape of the 14-3-3 dimer is modelled on the surface 
electrostatic potential [22]. N and C denote the amino- and carboxy-termini of each subunit. The filled circle indicates the position of the in vivo 
phosphorylated Ser185 [6] present in the phospho forms offl and ~" 14-3-3. The adjacent shaded portion is the annexin-similarity domain which is 
also on the surface of 14-3-3 and which has also been proposed to be involved in protein-protein interaction [18]. The double-headed arrow indicates 
interaction between the hypothetical signalling molecules A and B. It is also possible that interaction with adjacent organelle- or membrane-associated 
protein(s) could be mediated by formation of the complex. 
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a number of isoforms can regulate the activity of protein kinase 
C, with different potencies [18]. e 14-3-3 is more similar in 
sequence to the plant and yeast homologues than it is to other 
mammalian isoforms [5] (indeed this is the reason it was chosen 
for detailed study), so if this isoform can form a heterodimer 
with (, it suggests all 14-3-3s can similarly dimerise. The ability 
of diverse members of this family to form heterodimers may 
play an important role in properties and functions: ( 14-3-3, for 
instance, is phosphorylated to approximately 40% in the brain 
(when it is called the ~ isoform), and this site is not present in 
r. Other isoforms may have different potential regulatory sites 
which could modulate activity. 
The crystal structure of a 14-3-3 protein has recently been 
elucidated [22]. This shows that residues within the region 
Gln8-Asp21 in one monomer form contacts with residues Ile65- 
Glu89 in the opposing monomer. The data reported here con- 
firm that the N-terminal 17 kDa domain alone is sufficient for 
dimer formation. The dimeric protein forms a large negatively- 
charged channel, the interior of which contains amino acids 
which are almost invariant in 24 members of the family (from 
plants, mammals, yeast and amphibians). This is potentially 
involved in locating the 14-3-3 dimer at the surface of a cell 
membrane via a conserved cytoskeletal or membrane-associ- 
ated protein (see Fig. 3). This could mediate the targetting to 
a specific location of the signal transduction proteins with 
which 14-3-3 interacts and lends further support for an 
'adapter' function for these proteins. 
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